Abstract:Background: The fate and functions of RNAs are coordinately regulated by RNA-binding proteins (RBPs), which are often dysregulated in various cancers. Known as a splicing regulator, RNA-binding motif protein 6 (RBM6) harbors tumor-suppressor activity in many cancers; however, there is a lack of research on the molecular targets and regulatory mechanisms of RBM6. Methods: In this study, we constructed an RBM6 knock-down (shRBM6) model in the HeLa cell line to investigate its functions and molecular targets. Then we applied improved RNA immunoprecipitation coupled with sequencing (iRIP-seq) and whole transcriptome sequencing approaches to investigate the potential role and RNA targets of RBM6. Results: Using The Cancer Genome Atlas dataset, we found that higher expression of RBM6 is associated with a better prognosis in many cancer types. In addition, we found that RBM6 knockdown promoted cell proliferation and inhibited apoptosis, demonstrating that RBM6 may act as an anti-oncogenic protein in cancer cells. RBM6 can regulate the alternative splicing (AS) of genes involved in DNA damage response, proliferation, and apoptosis-associated pathways. Meanwhile, RBM6 knockdown activated type I interferon signaling pathways and inhibited the expression of genes involved in the cell cycle, cellular responses to DNA damage, and DNA repair pathways. The differentially expressed genes (DEGs) by shRBM6 and their involved pathways were likely regulated by the transcription factors undergoing aberrant AS by RBM6 knockdown. For iRIP-seq analysis, we found that RBM6 could interact with a large number of mRNAs, with a tendency for binding motifs GGCGAUG and CUCU. RBM6 bound to the mRNA of cell proliferation- and apoptosis-associated genes with dysregulated AS after RBM6 knockdown. Conclusions: In summary, our study highlights the important role of RBM6, as well as the downstream targets and regulated pathways, suggesting the potential regulatory mechanisms of RBM6 in the development of cancer.

The AS‐RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation

Cross-talk Between PRMT1-mediated Methylation and Ubiquitylation on RBM15 Controls RNA Splicing

87 Overexpression of mitochondrial Leucyl-tRNA synthetase restore the mitochondrial dysfunctions caused by the MELAS-associated tRNALeu(UUR) A3243G mutation

Arginine Methylation Of Rbm15 By Prmt1 Controls Alternative Splicing Of Genes Involved In Megakaryocyte Differentiation

RBM15 Promotes Hepatocellular Carcinoma Progression by Regulating N6-methyladenosine Modification of YES1 Mrna in an IGF2BP1-dependent Manner.

Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway

RBM15 drives the progression of lung adenocarcinoma by regulating N6-methyladenosine-mediated LDHA mRNA stability

RBFOX2 Recognizes N6-methyladenosine to Suppress Transcription and Block Myeloid Leukaemia Differentiation

RNA Binding Motif Protein 10 Suppresses Lung Cancer Progression by Controlling Alternative Splicing of Eukaryotic Translation Initiation Factor 4H

Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.

Rbm15 Functions In Blood Diseases

RBM15 Protects From Myocardial Infarction by Stabilizing NAE1

KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression

RBFOX2 recognizes N 6 -methyladenosine to suppress transcription and block myeloid leukaemia differentiation

Global RNA Interaction and Transcriptome Profiles Demonstrate the Potential Anti-Oncogenic Targets and Pathways of RBM6 in HeLa Cells

RBM15 condensates modulate m 6 A modification of STYK1 to promote tumorigenesis

RNA methylase RBM15 facilitates malignant progression of colorectal cancer through regulating E2F2 in an m6A modification‐dependent manner

RNA-binding Proteins As Drivers of AML and Novel Therapeutic Targets.

RBM15 Functions in Blood Diseases.

RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC

Effect of Long Noncoding RNA RUNXOR on the Epigenetic Regulation of RUNX1 in Acute Myelocytic Leukemia.